刘月高,钱永兵,田锐,金卫,葛芳侠,吕慧,陆健. 创伤大输血患者死亡危险因素分析[J]. 中国急救医学, 2018, 38(1): 57-62.
Liu Yue-gao, Qian Yong-bing, Tian Rui, Jin Wei, Ge Fang-xia, Lv Hui, Lu Jian. Mortality risk factors analysis of trauma patients with massive transfusion. Chinese Journal of Critical Care Medicine, 2018, 38(1): 57-62.
[1]Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline[J]. Crit Care, 2013, 17(2):R76.
[2]Duchesne JC, McSwain NE Jr, Cctton BA, et al. Damage control resuscitation:The new face of damage control[J]. J Trauma, 2010, 69(4):976-990.
[3]Como JJ, Dutton RP, Scalea TM, et al. Blood transfusion rates in the care of acute trauma[J]. Transfusion, 2004, 44(6) :809-813.
[4]Cotton BA, Au BK, Nunez TC, et al. Predefined Massive Transfusion Protocols are Associated With a Reduction in Organ Failure and Postinjury Complications[J]. J Trauma, 2009, 66(1):41-48.
[5]刘月高,王瑞兰.急性创伤性凝血病的最新研究进展[J].中国急救医学, 2016, 36(2):186-190.
[6]Spence RK, Jeter EK. Transfusion in surgery and trauma [M]. In:Mintz PD, editor. Transfusion therapy:clinical principles and practice. Bethesda, MD:AABB Press, 1999:171-197.
[7]Neugebauer E, Hensler T, Rose S, et al. Severe craniocerebral trauma in multiple trauma. An assessment of the interaction of local and systemic mediator responses [J].Unfallchirurg, 2000, 103(2):122-131.
[8]Vincent JL,Baron JF,Reinhart K,et al.Anemia and blood transfusion in critically ill patients[J].JAMA, 2002, 288(12):1499-1507.
[9]陆健,钱永兵,夏丰,等.严重骨盆骨折合并多发伤的早期急诊救治流程评估[J].中华创伤杂志 [J], 2012, 28(4):296-300.
[10]Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affectsmortality in patients receiving massive transfusions at a combat support hospital[J]. J Trauma, 2007, 63(4): 805-813.
[11]Gunter OL Jr, Au BK, Isbell JM, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associate with improved survival[J]. J Trauma, 2008, 65(3): 527-534.
[12]Kauvar DS, Holcomb JB, Norris GC, et al. Freshwhole blood transfusion: a controversial military practice[J]. J Trauma, 2006, 61(1): 181-184.
[13]Murdock AD, Berseus O, Herviq T, et al. Whole blood:the future of traumatic hemorrhagic shock resuscitation[J]. shock, 2014, 41(Suppl 1):62-69.
[14]Dirks J, Jorgensen H, Jensen CH, et al. Blood product ratio in acute traumatic coagulopathy - effect on mortality in a Scandinavian level 1 trauma centre[J]. Scand J Trauma Resusc Emerg Med, 2010, 18:65.
[15]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1∶1∶1 vs a 1∶1∶2 ratio and mortality in patients with severe trauma:the PROPPR randomized clinical trial[J]. JAMA, 2015, 313(5):471-482.
[16]Nascimento B, Callum J, Tien H, et al. Effect of a fied-ratio (1∶1∶1 ) transfusion protocol versus laboratory-results–guided transfusion in patients with severe trauma: a randomized feasibility trial[J]. CMAJ, 2013, 185(12):E583-589.
[17]Pommerening MJ, Goodman MD, Holcomb JB, et al. Clinical gestalt and the prediction of massive transfusion after trauma[J]. Injury, 2015, 46(5):807-813.
[18]Rainer TH, Ho AM, Yeung JH, et al. Early risk stratification of patients with major trauma requiring massive blood transfusion[J]. Resuscitation, 2011, 82(6):724-729.
[19]Wardie NS, Haddad FS. Peivic facturesand high energytraumas[J]. Hosp Med , 2005, 66(2):396-398.
[20]Lindahl J, Handolin L, Sderlund T, et al. Angiographic embolization in the treatment of arterial pelvic hemorrhage: evaluation of prognostic mortality-related factors[J]. Eur J Trauma Emerg Surg, 2013, 39 (1): 57-63.
[21]Smith W,Williams A,Agudelo J.et al.Early predictors of mortality in hemodynamically unable pelvis factures[J].J Orthop Trauma,2007, 21(1):31-37.
[22]Rossaint R, Cemy V, Coats TJ, et al. Key issues in advanced bleeding care in trauma[J].Shock, 2006, 26(4):322-331.
[23]Yamazaki Y, Salto A, Hasegawa K, et al. Blood lactate concentrations as predictors of outcome in serious hemorrhagic shock patients[J]. Masui, 2006, 55(6) :699-703.
[24]大量输血现状调研协作组.大量输血指导方案( 推荐稿) [J].中国输血杂志, 2012, 25(7):617-621.